- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06310317
Applied Behavior Analysis With Technologies
Evaluating the Effect of Use of Technologies to Increase the Cognitive Abilities in Children With Autism Spectrum Disorders
Applied Behavior Analysis (ABA) is a therapeutic approach for autism that is based on the principles of behavioral theory, learning, and positive reinforcement. Current research shows that early and intensive ABA intervention is effective in reducing dysfunctional behaviors and promoting learning and enactment of socially appropriate behaviors.
In this context, new approaches that attempt to integrate advanced technologies can play a key role. This experimental protocol aims to test whether the use of advanced technologies, such as tablets, as part of an intervention for a group of children with autism spectrum disorder (ASD) is more effective than the traditional approach implemented in a control group of children with ASD. The experimental protocol is aimed at enhancing cognitive skills, increasing new skills and acquiring functional/adaptive behaviors.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Flavia Marino
- Phone Number: +393395798263
- Email: flavia.marino@irib.cnr.it
Study Contact Backup
- Name: Maria Valeria Maiorana
- Phone Number: +393285856656
- Email: mvaleriamaiorana@gmail.com
Study Locations
-
-
-
Messina, Italy, 98164
- Recruiting
- Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
-
Contact:
- Flavia Marino
- Phone Number: +393395798263
- Email: flavia.marino@irib.cnr.it
-
Principal Investigator:
- Flavia Marino
-
Sub-Investigator:
- Giovanni Pioggia
-
Sub-Investigator:
- Paola Chilà
-
Sub-Investigator:
- Roberta Minutoli
-
Sub-Investigator:
- Noemi Vetrano
-
Sub-Investigator:
- Chiara Failla
-
Sub-Investigator:
- Germana Doria
-
Sub-Investigator:
- Ileana Scarcella
-
Contact:
- Maria Valeria Maiorana
- Phone Number: +393285856656
- Email: mariavaleria.maiorana@irib.cnr.it
-
Sub-Investigator:
- Cinzia Grasso
-
Sub-Investigator:
- Mariaelena Franchina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children with diagnosis of autism
Exclusion Criteria:
- presence of other medical disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: experimental group
15 children belonging to the experimental group will undergo the treatment carries out the procedure by means of stimuli presented with technologies supports
|
The main objective of the experimental protocol is to promote the development of cognitive skills, facilitate the acquisition of new skills and promote the adoption of functional and adaptive behaviors. The use of Applied Behavior Analysis procedures, with the help of technological tools such as a tablet or robot can facilitate the increase of new knowledge and skills. The criterion is acquired if the subject emits 8 out of 10 independent correct responses (90%) for 3 consecutive sessions. The objective is to test whether the technological tool used (tablet or robot) can make the proposed learning procedure more effective. The experimental group carries out the procedure by means of stimuli presented on tablets or robots. |
Other: control group
15 children belonging to the control group will undergo the treatment by performing the procedure with images printed on laminated A4 sheets.
|
The main objective of the experimental protocol is to promote the development of cognitive skills, facilitate the acquisition of new skills and promote the adoption of functional and adaptive behaviors.
In this group the materials are traditional, such as image printed.
The criterion is acquired if the subject emits 9 out of 10 independent correct responses (90%) for 3 consecutive sessions.
The control group performs the procedure with images printed on A4 laminated sheets.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Verbal Behavior Milestones Assessment and Placement Program (VB-MAPP)
Time Frame: the test need approximately 1 hour
|
Is an assessment tool that attends to all those skills that are fundamental to the development and enhancement of verbal communication skills and the proper use of language in social interactions. It focuses especially on the assessment of language prerequisites fundamental to the development of verbal behavior in accordance with the classification of verbal operants proposed by Skinner: mand, tact, echoic, intraverbal. It consists of a manual, a protocol and a set of materials (pictures and standardized items for assessment). The protocol is divided into:
|
the test need approximately 1 hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Flavia Marino, Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
Publications and helpful links
General Publications
- Choi KR, Bhakta B, Knight EA, Becerra-Culqui TA, Gahre TL, Zima B, Coleman KJ. Patient Outcomes After Applied Behavior Analysis for Autism Spectrum Disorder. J Dev Behav Pediatr. 2022 Jan 1;43(1):9-16. doi: 10.1097/DBP.0000000000000995.
- Yu Q, Li E, Li L, Liang W. Efficacy of Interventions Based on Applied Behavior Analysis for Autism Spectrum Disorder: A Meta-Analysis. Psychiatry Investig. 2020 May;17(5):432-443. doi: 10.30773/pi.2019.0229. Epub 2020 May 8.
- Valencia K, Rusu C, Quinones D, Jamet E. The Impact of Technology on People with Autism Spectrum Disorder: A Systematic Literature Review. Sensors (Basel). 2019 Oct 16;19(20):4485. doi: 10.3390/s19204485.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CNR-IRIB-PRO-2024-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Applied Behavior Analysis protocol
-
The Cleveland ClinicCVS Caremark; O'Neill FoundationTerminated
-
Karolinska InstitutetCompleted
-
IRCCS Eugenio MedeaRecruitingAutism Spectrum Disorder | Early InterventionItaly
-
University of Electronic Science and Technology...Recruiting
-
Federal University of São PauloUniversity of Sao Paulo; Mackenzie Presbiterian University, São Paulo, BrazilCompletedAutism Spectrum DisordersBrazil
-
Atatürk Chest Diseases and Chest Surgery Training...CompletedThoracic Surgery | C-reactive Protein | Enhanced Recovery After Thoracic Surgery Protocol | White Blood Cell Count | Neutrophil/Lymphocyte Ratio | Plathelet/ Lymphocyte Ratio | Lymphocyte/Monocytes RatioTurkey
-
Stanford UniversityNational Institute of Neurological Disorders and Stroke (NINDS)RecruitingMigraine | Migraine Disorders | Headache | Headache Disorders | Chronic Migraine | Lifestyle FactorsUnited States
-
Experiad LLCNational Institute of Mental Health (NIMH); University of Washington; northwest...UnknownAutistic DisorderUnited States
-
Universidade Federal de Sao CarlosUnknownShoulder Injury | Muscle FatigueBrazil
-
Babes-Bolyai UniversityUniversity of Plymouth; Vrije Universiteit Brussel; University of Portsmouth; University... and other collaboratorsCompletedAutistic Disorders SpectrumRomania